AI Summary

Researchers at UT Southwestern Medical Center identified a brain signaling pathway that appears to drive the substantial weight gain associated with clozapine, a commonly prescribed antipsychotic for treatment‑resistant schizophrenia. The preclinical study, published in *Nature Communications*, suggests that targeting this pathway could reduce clozapine’s metabolic side effects.

AI summaries can be wrong sometimes—always verify important details using the source article.